HBCM
MRNA icon

Heron Bay Capital Management’s Moderna MRNA Stock Holding History

Heron Bay Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,893
Closed -$444K – 94
2023
Q1 		$444K Buy
+2,893
New +$477K 0.17% 66
2021
Q4 		– Sell
-533
Closed -$205K – 72
2021
Q3 		$205K Buy
+533
New +$197K 0.11% 68

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Heron Bay Capital Management's MRNA Position: Q2 2023 in Review

Heron Bay Capital Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,893 shares — an estimated $444K sold.

Heron Bay Capital Management first reported a position in MRNA in Q3 2021 and held it in 2 quarters. The position peaked at $444K in Q1 2023. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Heron Bay Capital Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Heron Bay Capital Management sold 2,893 Moderna shares in Q2 2023, an estimated $444K.
  • Heron Bay Capital Management first reported a position in Moderna in Q3 2021 and held it in 2 quarters.
  • Heron Bay Capital Management's Moderna position peaked at $444K in Q1 2023.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Heron Bay Capital Management's 13F filing for Q2 2023, filed 12 Jul 2023.